Management

Karl Tobieson

Karl Tobieson

CEO

Born 1974. Employed since 2020
Nationality: Swedish

Previous experience:
Karl Tobieson was CEO of MedCap AB (publ) 2008-2020. Prior to that, he ran a corporate finance company together with a partner and before that he was Investment Manager at Centrecourt and Cell Innovation. Karl Tobieson began his career as a trainee at Volvo.

Education:
Karl Tobieson has a master’s degree in mechanical engineering with a focus on industrial economics, from the Royal Institute of Technology in Stockholm.

Other current positions:
Chairman of the board of MedCap AB.

Previous positions (past five years):
CEO of MedCap AB (publ), Chairman of the Board of Unimedic AB, Unimedic Pharma AB, Unimedic Pharma Holding AB, Cardiolex Medical AB and Abilia Sverige Holding AB, Board member of Cardiolex AB and Dunmedic AB, Deputy Board member of Abilia AB and Cross Pharma AB.

Shareholding in Linc AB:
2 000 000 shares. ​

Thomas Bergh

Thomas Bergh

CFO

Other current positions: Thomas holds no other assignments.CFO since 2020

Born 1982. Nationality: Swedish

Previous experience:
Thomas Bergh was investment manager at MedCap AB (publ) 2016-2020. Prior to that, he worked for nine years in investment banking at Morgan Stanley in Stockholm and UBS in London.

Education:
Thomas Bergh has a MSc in Finance from Stockholm School of Economics

Other current positions: Board member of nWise AB, nWise Ägare AB, Animal Probiotics Sweden AB and Oncorena Holding AB.

Previous positions (past five years): Investment manager at MedCap AB (publ), board member of Cardiolex Medical AB.

Shareholding in Linc AB:
1000 000 shares​